Helen Barker has been appointed director of regulatory affairs at Blue Earth Diagnostics, a UK headquartered pharmaceutical company developing molecular imaging agents for cancer. Helen has over twenty years’ experience in the management of regulatory affairs for the global pharmaceutical industry. She has deep sector expertise, having worked at levels of increasing seniority with a number of leading pharmaceutical companies including GSK, Janssen and Abbvie. Helen graduated from the University of Warwick with a degree in Microbiology and Microbial Technology, and has a PhD from Southampton University, where she studied the mechanism of action of antimicrobial peptides.